143 related articles for article (PubMed ID: 12093273)
1. Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface.
Vranken W; Tolkatchev D; Xu P; Tanha J; Chen Z; Narang S; Ni F
Biochemistry; 2002 Jul; 41(27):8570-9. PubMed ID: 12093273
[TBL] [Abstract][Full Text] [Related]
2. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
Riechmann L
J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
[TBL] [Abstract][Full Text] [Related]
3. A peptide mimic of an antigenic loop of alpha-human chorionic gonadotropin hormone: solution structure and interaction with a llama V(HH) domain.
Ferrat G; Renisio JG; Morelli X; Slootstra J; Meloen R; Cambillau C; Darbon H
Biochem J; 2002 Sep; 366(Pt 2):415-22. PubMed ID: 11996668
[TBL] [Abstract][Full Text] [Related]
4. Thermal unfolding of a llama antibody fragment: a two-state reversible process.
Pérez JM; Renisio JG; Prompers JJ; van Platerink CJ; Cambillau C; Darbon H; Frenken LG
Biochemistry; 2001 Jan; 40(1):74-83. PubMed ID: 11141058
[TBL] [Abstract][Full Text] [Related]
5. Structural and dynamic properties of the Fv fragment and the single-chain Fv fragment of an antibody in solution investigated by heteronuclear three-dimensional NMR spectroscopy.
Freund C; Ross A; Plückthun A; Holak TA
Biochemistry; 1994 Mar; 33(11):3296-303. PubMed ID: 8136365
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding interface between the E-domain of Staphylococcal protein A and an antibody Fv-fragment.
Meininger DP; Rance M; Starovasnik MA; Fairbrother WJ; Skelton NJ
Biochemistry; 2000 Jan; 39(1):26-36. PubMed ID: 10625476
[TBL] [Abstract][Full Text] [Related]
7. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.
Harmsen MM; Ruuls RC; Nijman IJ; Niewold TA; Frenken LG; de Geus B
Mol Immunol; 2000 Aug; 37(10):579-90. PubMed ID: 11163394
[TBL] [Abstract][Full Text] [Related]
8. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.
Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H
Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233
[TBL] [Abstract][Full Text] [Related]
9. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
[TBL] [Abstract][Full Text] [Related]
10. Improving solubility and refolding efficiency of human V(H)s by a novel mutational approach.
Tanha J; Nguyen TD; Ng A; Ryan S; Ni F; Mackenzie R
Protein Eng Des Sel; 2006 Nov; 19(11):503-9. PubMed ID: 16971398
[TBL] [Abstract][Full Text] [Related]
11. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
Jäger M; Plückthun A
J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
[TBL] [Abstract][Full Text] [Related]
12. The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3.
Pei XY; Holliger P; Murzin AG; Williams RL
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9637-42. PubMed ID: 9275175
[TBL] [Abstract][Full Text] [Related]
13. Backbone assignment, secondary structure and protein A binding of an isolated, human antibody VH domain.
Riechmann L; Davies J
J Biomol NMR; 1995 Sep; 6(2):141-52. PubMed ID: 8589603
[TBL] [Abstract][Full Text] [Related]
14. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
15. Analysis and modeling of the variable region of camelid single-domain antibodies.
Sircar A; Sanni KA; Shi J; Gray JJ
J Immunol; 2011 Jun; 186(11):6357-67. PubMed ID: 21525384
[TBL] [Abstract][Full Text] [Related]
16. Selection by phage display of llama conventional V(H) fragments with heavy chain antibody V(H)H properties.
Tanha J; Dubuc G; Hirama T; Narang SA; MacKenzie CR
J Immunol Methods; 2002 May; 263(1-2):97-109. PubMed ID: 12009207
[TBL] [Abstract][Full Text] [Related]
17. Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability.
Davies J; Riechmann L
Protein Eng; 1996 Jun; 9(6):531-7. PubMed ID: 8862554
[TBL] [Abstract][Full Text] [Related]
18. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
[TBL] [Abstract][Full Text] [Related]
19. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
[TBL] [Abstract][Full Text] [Related]
20. 'Camelising' human antibody fragments: NMR studies on VH domains.
Davies J; Riechmann L
FEBS Lett; 1994 Feb; 339(3):285-90. PubMed ID: 8112468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
